(0.10%) 5 301.00 points
(0.01%) 38 795 points
(0.26%) 18 640 points
(-0.04%) $76.96
(3.98%) $2.69
(-0.06%) $2 344.40
(-0.59%) $30.26
(-0.36%) $1 038.30
(0.05%) $0.922
(0.01%) $10.49
(0.09%) $0.786
(-1.19%) $89.36
Live Chart Being Loaded With Signals
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases...
Stats | |
---|---|
本日の出来高 | 106.00 |
平均出来高 | 0.00 |
時価総額 | 40.85M |
EPS | $-0.570 ( 2023-06-29 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.0140 (4.70%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-20 | Saxena Parag | Buy | 585 366 | Common Stock Warrant (right to buy) |
2023-11-20 | Saxena Parag | Buy | 585 366 | Pre-Funded Warrant |
2023-11-13 | Patel Purav | Buy | 8 200 | Stock Option (right to buy) |
2023-11-13 | Saxena Parag | Buy | 8 200 | Stock Option (right to buy) |
2023-04-25 | Bhat Laxminarayan | Buy | 443 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 69 transactions |
Buy: 9 274 957 | Sell: 2 515 186 |
Reviva Pharmaceuticals 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Reviva Pharmaceuticals 財務諸表
Annual | 2022 |
収益: | $0 |
総利益: | $0 (0.00 %) |
EPS: | $-1.250 |
FY | 2022 |
収益: | $0 |
総利益: | $0 (0.00 %) |
EPS: | $-1.250 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $0 |
FY | 2020 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Reviva Pharmaceuticals
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company\'s lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer\'s disease, Parkinson\'s disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company was founded in 2018 and is based in Cupertino, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。